Project Grant K43TW013133
Award Date 9/16/25
Completion Date 8/31/30
Dollars Obligated $104K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nigeria
Similar Awards
- This federal Project Grant award of $1,839,317.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Illinois. The grant aims to evaluate the interrelated roles of environmental exposures and multi-omic factors on high-risk prostate cancer among men of African ancestry. Key components include: Establishing a translational study site at the University of Calabar Teaching Hospital in Nigeria to recruit 120...
- This $584,828 federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the "HEROIC PROSTATE CANCER PRECISION HEALTH (PCAPH) AFRICA1K: POWERING PRECISION HEALTH TO IMPROVE PROSTATE CANCER OUTCOMES IN AFRICA" initiative. The grant, awarded to the University of Nairobi, a prominent Kenyan research university, aims to conduct advanced biomedical research and capacity-building focused on improving...
- The National Cancer Institute (NCI) awarded a $386,866 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the Regents of the University of Michigan to develop individualized estimates of treatment benefit from hormone therapy for men with prostate cancer. The project aims to integrate models for other-cause mortality risk, distant metastases, and prostate cancer-specific mortality to provide personalized estimates of treatment outcomes, and to develop a web...
- The U.S. National Cancer Institute (NCI) awarded a 5-year, $680,433 Project Grant to the University of California, San Francisco (UCSF) under the NCI's Cancer Detection and Diagnosis Research (CFDA 93.394) program. The grant supports research aimed at using cutting-edge spatial proteogenomic technologies and pathology artificial intelligence (PAI) to improve prognostic estimation and elucidate the underlying biology driving PAI outcomes in prostate cancer. The project seeks to: 1) understand the...
- The University of Southern California (USC) received a $704,882 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) to define the genetic factors underlying familial prostate cancer in African American (AA) men. The project aims to develop improved risk prediction models that incorporate polygenic risk scores, pathogenic variants, and family history of prostate cancer for the AA population. By leveraging existing...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $603,981 to the University of Wisconsin-Madison to conduct research on integrated clinical-grade genomic and pathology artificial intelligence (AI) biomarkers for high-risk prostate cancer. The key objectives are to: 1) validate genomic and pathology AI as prognostic biomarkers for high-risk prostate cancer patients; 2) validate genomic and pathology AI as...
- This $681,215 federal Project Grant was awarded on September 1, 2025 by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to New York University (NYU) to develop AI-powered diagnostic tools for early prostate cancer detection. The project aims to leverage machine learning models to infer the presence of clinically significant prostate cancer using a minimal amount of degraded MRI data, in order to enable widespread, cost-effective population-level disease...
- This Project Grant award, totaling $354,658, was provided by the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to The Johns Hopkins University. The objective is to perform a systematic analysis of P27 alterations in both primary and metastatic prostate cancer, with the ultimate aim of understanding how subclonal P27 loss mediates worse prostate cancer outcomes, particularly in African American males who experience higher mortality rates from the disease. This research...
- This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $371,161 to develop advanced AI-based risk models for cervical cancer screening in low-resource settings. The project aims to leverage time-series imaging data and self-supervised learning to enhance the diagnostic accuracy of automated visual evaluation (AVE) models. The goal is to create a comprehensive risk stratification system that combines imaging data, HPV...
- The National Cancer Institute awarded a $717,667 Project Grant titled "Artificial Intelligence Enabled Stroma-Weighted Automated Grading System to Improve Risk Stratification in Black Men" under the Cancer Detection and Diagnosis Research program (CFDA 93.394). The grant aims to develop an AI-enabled automated grading system that leverages multiphoton microscopy and second harmonic generation imaging to analyze prostate cancer tumor biology and improve risk stratification, particularly...